The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)
Titel:
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)
Auteur:
Gobbi, P.G. Broglia, C. Valentino, F. Mammi, C. Lombardo, M. Merli, F. Luminari, S. Polimeno, G. Riezzo, A. Lambelet, P. Rovati, A. Corazza, G.R. Federico, M.